Dr. Richard L. Martin

Hematology Oncology
776 Weatherly Dr, Suite A, 
Clarksville, TN 
Accepting New Patients
Offers Telehealth
776 Weatherly Dr, Suite A, 
Clarksville, TN 
OverviewInsuranceLocationsClinical Research

Overview

Richard Martin is a Hematologist Oncology provider in Clarksville, Tennessee. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Chronic Familial Neutropenia, and Agranulocytosis. Dr. Martin is currently accepting new patients.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in TN
Hospital Affiliations
Tristar Skyline Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

TENNESSEE ONCOLOGY PLLC
776 Weatherly Dr, Suite A, Clarksville, TN 37043

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails
A Randomised Controlled Multicentre Trial of Imiquimod Versus Radiotherapy for Lentigo Maligna (LM) When Staged Surgical Excision With 5mm Margins is Not Possible, is Refused, or Fails
Enrollment Status: Completed
Publish Date: June 20, 2024
Intervention Type: Drug, Radiation
Study Drug: Imiquimod
Study Phase: Phase 3
View 1 Less Clinical Trial

11 Total Publications

Cancer Care Without a Safety Net-How Oncology Practices Confront the Gap.
Cancer Care Without a Safety Net-How Oncology Practices Confront the Gap.
Journal: JAMA oncology
Published: August 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Martin's expertise for a condition
ConditionClose
      View All 21 Advanced Conditions
      View All 118 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile